Bicycle Therapeutics Shares Owned By Insiders vs. Revenue
| BCYC Stock | USD 20.40 0.45 2.26% |
For Bicycle Therapeutics profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Bicycle Therapeutics to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Bicycle Therapeutics utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Bicycle Therapeutics's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Bicycle Therapeutics over time as well as its relative position and ranking within its peers.
Bicycle |
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Bicycle Therapeutics. If investors know Bicycle will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Bicycle Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (3.19) | Revenue Per Share 0.716 | Quarterly Revenue Growth (0.50) | Return On Assets (0.15) | Return On Equity (0.27) |
The market value of Bicycle Therapeutics is measured differently than its book value, which is the value of Bicycle that is recorded on the company's balance sheet. Investors also form their own opinion of Bicycle Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Bicycle Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Bicycle Therapeutics' market value can be influenced by many factors that don't directly affect Bicycle Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Bicycle Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Bicycle Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Bicycle Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Bicycle Therapeutics Revenue vs. Shares Owned By Insiders Fundamental Analysis
Comparative valuation techniques use various fundamental indicators to help in determining Bicycle Therapeutics's current stock value. Our valuation model uses many indicators to compare Bicycle Therapeutics value to that of its competitors to determine the firm's financial worth. Bicycle Therapeutics is rated below average in shares owned by insiders category among its peers. It is rated third in revenue category among its peers totaling about 20,911,628 of Revenue per Shares Owned By Insiders. At present, Bicycle Therapeutics' Total Revenue is projected to increase significantly based on the last few years of reporting. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Bicycle Therapeutics' earnings, one of the primary drivers of an investment's value.Bicycle Revenue vs. Shares Owned By Insiders
Shares Owned by Insiders show the percentage of outstanding shares owned by insiders (such as principal officers or members of the board of directors) or private individuals and entities with over 5% of the total shares outstanding. Company executives or private individuals with access to insider information share information about a firm's operations that is not available to the general public.
Bicycle Therapeutics |
| = | 1.29 % |
Although the research on effects of insider trading on prices and volatility is still relatively inconclusive, and investors are advised to pay close attention to the distribution of equities among company's stakeholders to avoid many problems associated with the disclosure of price-sensitive information.
Revenue is income that a firm generates from business activities such us rendering services or selling goods to customers. It is a crucial part of a business and an essential item when evaluating a company's financial statements. Revenues from a firm's primary business operations can be reported on the income statement as sales revenue, net sales, or simply sales, depending on the industry in which a given company operates.
Bicycle Therapeutics |
| = | 26.98 M |
Revenue is typically recorded when cash or cash equivalents are exchanged for services or goods and can include products or services discounts, promotions, as well as early payments on invoices or services rendered in advance.
Bicycle Revenue vs Competition
Bicycle Therapeutics is rated third in revenue category among its peers. Market size based on revenue of Health Care industry is currently estimated at about 247.55 Million. Bicycle Therapeutics retains roughly 26.98 Million in revenue claiming about 11% of equities under Health Care industry.
Bicycle Therapeutics Profitability Projections
The most important aspect of a successful company is its ability to generate a profit. For investors in Bicycle Therapeutics, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Bicycle Therapeutics will eventually generate negative long term returns. The profitability progress is the general direction of Bicycle Therapeutics' change in net profit over the period of time. It can combine multiple indicators of Bicycle Therapeutics, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
| Last Reported | Projected for Next Year | ||
| Accumulated Other Comprehensive Income | -1.3 M | -1.4 M | |
| Interest Income | 14 M | 14.7 M | |
| Operating Income | -189.9 M | -180.4 M | |
| Net Loss | -180.7 M | -171.6 M | |
| Income Before Tax | -179.2 M | -170.2 M | |
| Total Other Income Expense Net | 10.7 M | 11.3 M | |
| Net Loss | -101.4 M | -96.4 M | |
| Net Loss | -180.7 M | -171.6 M | |
| Income Tax Expense | 1.5 M | 1.5 M | |
| Net Interest Income | 10.7 M | 11.3 M | |
| Change To Netincome | 25.6 M | 26.9 M | |
| Net Loss | (5.08) | (5.33) | |
| Income Quality | 0.34 | 0.65 | |
| Net Income Per E B T | 1.01 | 1.09 |
Bicycle Profitability Driver Comparison
Profitability drivers are factors that can directly affect your investment outlook on Bicycle Therapeutics. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Bicycle Therapeutics position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Bicycle Therapeutics' important profitability drivers and their relationship over time.
Use Bicycle Therapeutics in pair-trading
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Bicycle Therapeutics position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Bicycle Therapeutics will appreciate offsetting losses from the drop in the long position's value.Bicycle Therapeutics Pair Trading
Bicycle Therapeutics Pair Trading Analysis
The ability to find closely correlated positions to Bicycle Therapeutics could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Bicycle Therapeutics when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Bicycle Therapeutics - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Bicycle Therapeutics to buy it.
The correlation of Bicycle Therapeutics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Bicycle Therapeutics moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Bicycle Therapeutics moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Bicycle Therapeutics can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Use Investing Themes to Complement your Bicycle Therapeutics position
In addition to having Bicycle Therapeutics in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Financials ETFs Thematic Idea Now
Financials ETFs
ETF themes focus on helping investors to gain exposure to a broad range of assets, diversify, and lower overall costs. The Financials ETFs theme has 45 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Financials ETFs Theme or any other thematic opportunities.
| View All Next | Launch |
Check out Trending Equities. For information on how to trade Bicycle Stock refer to our How to Trade Bicycle Stock guide.You can also try the Financial Widgets module to easily integrated Macroaxis content with over 30 different plug-and-play financial widgets.
To fully project Bicycle Therapeutics' future profitability, investors should examine all historical financial statements. These statements provide investors with a comprehensive snapshot of the financial position of Bicycle Therapeutics at a specified time, usually calculated after every quarter, six months, or one year. Three primary documents fall into the category of financial statements. These documents include Bicycle Therapeutics' income statement, its balance sheet, and the statement of cash flows.